🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆
Updated 04 Jul 2026 · HPRA open data

Teva B.V. — Licensed Medicines

170 medicines held by Teva B.V. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 170 products held by Teva B.V.
MedicineActive substanceLicence holderStatus
Abiraterone Teva 500 mg film-coated tablets
PA1986/103/001
 Abiraterone acetate Teva B.V. Marketed
Anidulafungin Teva 100 mg Powder for Concentrate for Solution for Infusion
PA1986/045/001
 Anidulafungin Teva B.V. Not marketed
Antabuse 400 mg Effervescent Tablets
PA1986/110/001
 Disulfiram Teva B.V. Marketed
Aripiprazole Teva 10 mg tablets
PA1986/019/002
 Aripiprazole Teva B.V. Marketed
Aripiprazole Teva 15 mg tablets
PA1986/019/003
 Aripiprazole Teva B.V. Marketed
Aripiprazole Teva 30 mg tablets
PA1986/019/004
 Aripiprazole Teva B.V. Marketed
Aripiprazole Teva 5 mg tablets
PA1986/019/001
 Aripiprazole Teva B.V. Marketed
Atorvastatin Teva Pharma 10 mg Film-coated tablets
PA1986/125/001
 Atorvastatin calcium Teva B.V. Marketed
Atorvastatin Teva Pharma 20 mg Film-coated tablets
PA1986/125/002
 Atorvastatin calcium Teva B.V. Marketed
Atorvastatin Teva Pharma 40 mg Film-coated tablets
PA1986/125/003
 Atorvastatin calcium Teva B.V. Marketed
Atorvastatin Teva Pharma 80 mg Film-coated tablets
PA1986/125/004
 Atorvastatin calcium Teva B.V. Marketed
AZILECT 1 mg tablets
EU/1/04/304/1-7
 Rasagiline Teva B.V. —
Bendamustine 100 mg Powder for Concentrate for Solution for Infusion
PA1986/121/002
 Bendamustine hydrochloride Teva B.V. Marketed
Bendamustine 25 mg Powder for Concentrate for Solution for Infusion
PA1986/121/001
 Bendamustine hydrochloride Teva B.V. Marketed
Braltus 10 microgram per delivered dose inhalation powder, hard capsule
PA1986/006/001
 Tiotropium bromide Teva B.V. Marketed
Buplex 200mg film-coated tablets
PA1986/116/001
 Ibuprofen Teva B.V. Marketed
Buplex 400mg film-coated tablets
PA1986/116/002
 Ibuprofen Teva B.V. Marketed
Buplex Rx 200 mg film-coated tablets
PA1986/117/001
 Ibuprofen Teva B.V. Marketed
Buplex Rx 400 mg film-coated tablets
PA1986/117/002
 Ibuprofen Teva B.V. Not marketed
Buplex Rx 600 mg film-coated tablets
PA1986/117/003
 Ibuprofen Teva B.V. Not marketed
Capecitabine Teva 150 mg film-coated tablets
EU/1/12/761/001
 Capecitabine Teva B.V. —
Capecitabine Teva 500 mg film-coated tablets
EU/1/12/761/002
 Capecitabine Teva B.V. —
Cetriz 10mg Film-coated Tablets
PA1986/114/001
 Cetirizine hydrochloride Teva B.V. Marketed
Cinacalcet Teva 30 mg film-coated tablets
PA1986/007/001
 TALC PH.EUR., Cinacalcet Teva B.V. Marketed
Cinacalcet Teva 60 mg film-coated tablets
PA1986/007/002
 Cinacalcet Teva B.V. Marketed
Cinacalcet Teva 90 mg film-coated tablets
PA1986/007/003
 Cinacalcet Teva B.V. Marketed
CINQAERO 10 mg/mL concentrate for solution for infusion
EU/1/16/1125/001
 Reslizumab Teva B.V. —
Clopidogrel ratiopharm 75 mg film-coated tablets
EU/1/14/975/001-017
 Clopidogrel Teva B.V. —
Clopidogrel Teva 75 mg film-coated tablets
EU/1/09/540/1-16
 Clopidogrel hydrogensulfate Teva B.V. —
COLOMYCIN 1 million International Units (IU) Powder for solution for injection, infusion or inhalation
PA1986/046/001
 Colistimethate sodium Teva B.V. Marketed
COLOMYCIN 2 million International Units (IU) Powder for solution for injection, infusion or inhalation
PA1986/046/002
 Colistimethate sodium Teva B.V. Marketed
Dasatinib Teva 100 mg Film-coated Tablets
PA1986/066/004
 Dasatinib Teva B.V. Marketed
Dasatinib Teva 20 mg Film-coated Tablets
PA1986/066/001
 Dasatinib Teva B.V. Marketed
Dasatinib Teva 50 mg Film-coated Tablets
PA1986/066/002
 Dasatinib Teva B.V. Marketed
Dasatinib Teva 70 mg Film-coated Tablets
PA1986/066/003
 Dasatinib Teva B.V. Marketed
Desloratadine Teva 5 mg film-coated tablets
EU/1/11/732/001-013
 Desloratadine Teva B.V. —
Dexamethasone phosphate Teva 4 mg/ml solution for injection
PA1986/105/001
 Dexamethasone sodium phosphate Teva B.V. Marketed
Doxycycline Teva 100mg Hard Capsules
PA1986/081/001
 Doxycycline Teva B.V. Marketed
Efavirenz Teva 600 mg film-coated tablets
EU/1/11/742/001-010
 Efavirenz Teva B.V. —
Efavirenz/Emtricitabine/Tenofovir disoproxil Teva 600 mg/200 mg/245 mg Film-coated Tablets
PA1986/033/001
 Efavirenz, Emtricitabine, Tenofovir disoproxil Teva B.V. Marketed
Emtricitabine/Tenofovir disoproxil Teva 200 mg/245 mg film-coated tablets
PA1986/016/001
 Emtricitabine, Tenofovir disoproxil Teva B.V. Marketed
Etoricoxib Teva 120 mg film-coated tablets
PA1986/002/004
 Etoricoxib Teva B.V. Marketed
Etoricoxib Teva 30 mg film-coated tablets
PA1986/002/001
 Etoricoxib Teva B.V. Marketed
Etoricoxib Teva 60 mg film-coated tablets
PA1986/002/002
 Etoricoxib Teva B.V. Marketed
Etoricoxib Teva 90 mg film-coated tablets
PA1986/002/003
 Etoricoxib Teva B.V. Marketed
Exemestane Teva 25 mg film-coated tablets
PA1986/115/001
 Exemestane Teva B.V. Marketed
Exorex Lotion 5% v/w Cutaneous Emulsion
PA1986/078/001
 Coal tar solution Teva B.V. Not marketed
Ezetimibe/Simvastatin Teva Pharma 10 mg/20 mg tablets
PA1986/067/001
 Ezetimibe, Simvastatin Teva B.V. Marketed
Ezetimibe/Simvastatin Teva Pharma 10 mg/40 mg tablets
PA1986/067/002
 Ezetimibe, Simvastatin Teva B.V. Marketed
Ezetimibe/Simvastatin Teva Pharma 10 mg/80 mg tablets
PA1986/067/003
 Ezetimibe, Simvastatin Teva B.V. Marketed
1 2 3 4 →
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 19 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.